Chart of the Day: Viking Therapeutics (VKTX) Just Exploded Higher
On October 31, we said Viking Therapeutics (VKTX) was a solid opportunity. Especially as the company was set to jump into Obesity Week where the company was presenting results from its Phase 2 VENTURE clinical trial with its subcutaneous formulation of VK2735....